GSK
-
Health
GSK’s cancer drug combination meets primary goal in late-stage trial, ET HealthWorld
New Delhi : GSK said on Monday that a combination of its cancer drugs Zejula and Jemperli, when as used…
Read More » -
Health
Drugmaker GSK settles California lawsuit on Zantac, Health News, ET HealthWorld
GSK on Wednesday said it had reached a confidential settlement on a litigation in California alleging that the British drugmaker’s…
Read More » -
Health
GSK signs shingles vaccine deal with China’s Zhifei for around $3 bln, ET HealthWorld
Shanghai: China’s largest vaccines company Zhifei will pay British drugmaker GSK 2.5 billion pounds ($3.05 billion pound) for the exclusive…
Read More » -
Business
IPO for J&J’s Consumer Health Division Coming Soon, CFO Says
IPO for J&J’s Consumer Health Division Coming Soon, CFO Says
Read More » -
Business
3 high-dividend healthcare stocks for passive income
The global economy has slowed significantly in recent times, mainly due to aggressive interest rate hikes carried out by central…
Read More » -
Business
Clovis Oncology shares slide 75% after biotech warns it will run out of money in January 2023
Shares of Clovis Oncology Inc. CLVS, -69.43% fell 75% on Wednesday, after the Colorado-based biotech company said it would not…
Read More » -
Business
Pfizer stock rises on earnings beat, releases strong RSV data
Pfizer the stock rose after the company income statement beat Wall Street’s expectations. Pfizer reported $22.6 billion in revenue for…
Read More » -
Business
Pfizer earnings are Tuesday. What to see.
Pfizer is expected to report its earnings on Tuesday, a week and a half after an executive told investors the…
Read More » -
Business
Johnson & Johnson earnings top estimates. Its chief financial officer explains what went right.
Follow Johnson & Johnson chief financial officer, sent back procedural volumes and resulted in an 8.1% increase in adjusted operating…
Read More »